Alternatives to Enveda Biosciences

Leveraging the adaptive immune system to diagnose and treat disease.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered platform for antibody discovery and development to create new medicines.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

AI-powered drug discovery and development platform for biologics.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.